Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion type Assertion NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_head.
- NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion description "[Moreover, an additive effect of GCKR rs1260326(T) and GCK (-30G) alleles conferred lower fasting glycemia (P = 1 x 10(-13)), insulinemia (P = 5 x 10(-6)), and hyperglycemia risk (P = 1 x 10(-6)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_provenance.
- NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion evidence source_evidence_literature NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_provenance.
- NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion SIO_000772 18556336 NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_provenance.
- NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion wasDerivedFrom befree-2016 NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_provenance.
- NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_assertion wasGeneratedBy ECO_0000203 NP676790.RADrxVJNETvpHMZB5hlVKjd6Nwsy6zw8Tn0ZVkcWvXF4w130_provenance.